亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

人參二醇 CAS:19666-76-3

 
 
單價 面議對比
詢價 暫無
發(fā)貨 四川成都市付款后3天內(nèi)
品牌 鈉鈳鋰
過期 長期有效
更新 2021-11-25 12:21
 

成都鈉鈳鋰生物科技有限公司

企業(yè)會員第5年
資料未認證
保證金未繳納
詳細說明

nkl-01104

中文名稱:人參二醇
中文別名:人參萜二醇
英文名稱:Panaxadiol
英文別稱:20(R)-Panaxadiol;
CAS號:19666-76-3
純度: HPLC≥98%

分子式:C30H52O3
分子量:460.73
外觀:白色粉末
熔點:244 - 250°C
沸點:531.3±45.0°C
密度:1.025±0.06克/立方厘米|條件:溫度:20°C
pKa:14.82±0.70 |條件:酸性最強溫度:25°C
提取來源:人參
藥理藥效:人參二醇組皂苷具有抗心肌缺血、抗脂質(zhì)過氧化以及免疫調(diào)節(jié)等藥理作用。

規(guī)格:10mg,20mg,50mg;可根據(jù)客戶需求包裝、定制

儲存條件: 低溫,避光、干燥、密封

用途: 用于鑒別、含量測定、藥理實驗、活性篩選等科研、實驗室使用;不得直接用于人體

供應(yīng)商:成都鈉鈳鋰生物科技有限公司

舉報收藏 0評論 0
更多>本企業(yè)其它產(chǎn)品
2”-O-沒食子酰基金絲桃苷 CAS:53209-27-1 甘草酸 CAS:1405-86-3 甘草酸銨 CAS:53956-04-0 甘草查爾酮A CAS:58749-22-7 甘草查爾酮B CAS:58749-23-8 甘草查爾酮C CAS:144506-14-9 重樓皂苷II CAS:50773-42-7 重樓皂苷III CAS:19057-60-4
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |